Definitive Contract 75D30118C03490
Award Date 9/27/18
Potential Completion Date 9/26/21
Potential Value $975K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90095, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $94,327 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) to conduct a study on the UCLA football program. As the prime contractor, UCLA will leverage its expertise and facilities in Los Angeles, California to perform the services. No set-aside designation was applied to this contract award. UCLA routinely supports government agencies through...
- The Centers for Disease Control and Prevention (CDC) awarded a $599,271 purchase order contract to the University of California, Los Angeles (UCLA), operating as the Office of Research Administration, as the prime contractor. The contract is for the CBBD PROJECT and will be performed in Los Angeles, California over a period of performance from January 24, 2022 to January 23, 2023. The pricing structure is firm fixed price. No subcontractors or additional context on products/services were...
- This federal contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) - doing business as the Office of Research Administration. The contract, valued at $521,259.82, provides for "MISCELLANEOUS ITEMS" in support of the National Children's Study - Los Angeles County Study Center. The contract is a definitive contract with...
- This is a $1,603,602.00 firm fixed-price definitive contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the University of California, Los Angeles (UCLA) for support of the RCADS data collection measure. The contract has an ultimate completion date of July 31, 2026. UCLA, a state-controlled institution of higher learning, frequently serves as a prime contractor for federal research and technical services. This contract is not set aside for any specific...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $749,000.00 firm fixed-price contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract involves research and development for scalable sequencing approaches to detect novel pathogens, with a focus on next-generation sequencing-based diagnostic tools for respiratory RNA virus pathogens. The contract has...
- This is a Firm Fixed Price definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of California, Los Angeles (UCLA) under the Broad Agency Announcement FDAVAA-19-00123-A3 "Strengthening the Global Product Safety Net, Research Area #9". The contract has a potential value of $723,268.00 and a performance completion date of March 14, 2022. The contract is not set aside for any small business designation. UCLA is performing...
- This federal contract award to the University of California, Los Angeles (UCLA) is for the execution of a balanced science program based on guidance from the National Academies, administration priorities, and direction from Congress. The contract has a ceiling value of $459,776 and is a grant for research, with a completion date of September 3, 2028. UCLA, as a prominent public research university, a U.S. state government entity, and an 1862 Land Grant College, is well-positioned to deliver...
- <p>The University of California, Los Angeles, doing business as the Office of Research Administration, was awarded a $749,507 definitive contract by the Centers for Disease Control and Prevention to extend the SwabSeq agnostic diagnostic platform. The contract has a start date of September 29, 2023 and end date of September 28, 2025, and utilizes a firm fixed price structure. Performance will take place in Los Angeles, California. No subcontractors were identified.</p>
- This federal contract award is for the BPHC NATIONAL PROGRAM PERFORMANCE ANALYSIS project, which was awarded to the University of California, Los Angeles (UCLA) by the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $1,069,367.49 and is a Firm Fixed Price Delivery Order issued under the HRSA Evaluation Studies 2013 indefinite delivery contract vehicle. The contract has no set-aside designation and will be performed at UCLA's facilities in Los Angeles,...
- This federal contract award, valued at $96,908.86, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Miami Research Administration - Coral Gables Division. The contract, which has a completion date of July 10, 2019, is for the "LEGACY FOR CHILDREN" program, a civilian initiative. The contract is a firm-fixed-price purchase order with no set-aside designation, indicating it was competed on an unrestricted basis. The University of Miami, a private...